Outcomes of Multimodality Breast Screening for Women at Increased Risk of Familial Breast Cancer

被引:7
|
作者
Bennett, Ian C. [1 ]
Muller, Jennifer [2 ]
Cockburn, Linda
Joshua, Helen
Thorley, Gillian [3 ]
Baker, Christine
Wood, Nili
Brazier, Jane
Jones, Mark [4 ]
Dunn, Nathan [5 ]
Gattas, Michael [6 ]
机构
[1] Univ Queensland, Dept Surg, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia
[2] Queensland Hlth, Canc Screening Serv, Brisbane, Qld, Australia
[3] BreastScreen Queensland, N Brisbane Serv, Familial Breast Canc Screening Clin, Brisbane, Qld, Australia
[4] Univ Queensland, Princess Alexandra Hosp, Sch Populat Hlth, Brisbane, Qld, Australia
[5] Queensland Hlth, BreastScreen Queensland, Monitoring, Brisbane, Qld, Australia
[6] Royal Brisbane Hosp, Queensland Clin Genet Serv, Brisbane, Qld 4006, Australia
关键词
BRCA2 MUTATION CARRIERS; MAMMOGRAPHY; HISTORY; SURVEILLANCE; SONOGRAPHY; MANAGEMENT; EFFICACY; GENE; SUSCEPTIBILITY; ULTRASOUND;
D O I
10.1007/s00268-010-0409-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
While population-based breast screening for women over the age of 50 years is a generally accepted and proven health strategy, the role of breast screening specifically among women at high risk of familial breast cancer has remained controversial. Indeed, there are very few services specifically offering a breast-screening program for women at high risk of familial breast cancer. In 1999 a Familial Breast Cancer Screening Clinic (FBCSC) was established at the North Brisbane BreastScreen Queensland Service to provide a regular multimodality screening program utilizing clinical breast examination, breast ultrasound, and mammography for women at higher risk of hereditary breast cancer and with entry into the program commencing from the age of 30 years. Since its inception, a total of 2440 women have participated in the FBCSC. A total 7051 breast-screening examinations have been performed on these participants, with 53 breast cancers being diagnosed, including 8 in situ ductal carcinomas, 38 invasive ductal carcinomas, and 7 invasive lobular carcinomas. The mean size of the cancers was 16 mm (range = 1-45 mm), and of the 45 invasive cancers, 60% were less than or equal to 15 mm in size. The overall axillary node positive rate was 24.5% (13/53). The invasive cancer detection rate for first-round screening was 8.3 cancers per 1000 women screened, with 5.2 cancers per 1000 women detected on subsequent round screening. The results from this service demonstrate that multimodality screening for women at high risk of familial breast cancer and including women of younger age is effective and appropriate, with very acceptable cancer detection rates and pathological cancer characteristics being observed consistent with early-stage detection. The colocated siting of this service within a BreastScreen Queensland facility has proven to be efficient and cost effective.
引用
收藏
页码:979 / 986
页数:8
相关论文
共 50 条
  • [31] Perceived risk and adherence to breast cancer screening guidelines among women with a familial history of breast cancer: A review of the literature
    Walker, Meghan J.
    Chiarelli, Anna M.
    Knight, Julia A.
    Mirea, Lucia
    Glendon, Gord
    Ritvo, Paul
    BREAST, 2013, 22 (04): : 395 - 404
  • [32] Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer
    Louise Heiniger
    Phyllis N. Butow
    Joseph Coll
    Tracey Bullen
    Judy Wilson
    Brandi Baylock
    Bettina Meiser
    Melanie A. Price
    Familial Cancer, 2015, 14 : 105 - 115
  • [33] Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer
    Heiniger, Louise
    Butow, Phyllis N.
    Coll, Joseph
    Bullen, Tracey
    Wilson, Judy
    Baylock, Brandi
    Meiser, Bettina
    Price, Melanie A.
    FAMILIAL CANCER, 2015, 14 (01) : 105 - 115
  • [34] Screening Familial Risk for Hereditary Breast and Ovarian Cancer
    Kiser, Daniel
    Elhanan, Gai
    Bolze, Alexandre
    Neveux, Iva
    Schlauch, Karen A.
    Metcalf, William J.
    Cirulli, Elizabeth T.
    McCarthy, Catherine
    Greenberg, Leslie A.
    Grime, Savanna
    Blitstein, Jamie M. Schnell
    Plauth, William
    Grzymski, Joseph J.
    JAMA NETWORK OPEN, 2024, 7 (09)
  • [35] Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
    Isfoss, Bjorn L.
    Holmqvist, Bo
    Jernstrom, Helena
    Alm, Per
    Olsson, Hakan
    BMC CLINICAL PATHOLOGY, 2013, 13
  • [36] LONG-TERM OUTCOMES OF RISK-REDUCING SURGERY IN UNAFFECTED WOMEN AT INCREASED FAMILIAL RISK OF BREAST AND/OR OVARIAN CANCER
    Heiniger, Louise
    Butow, Phyllis N.
    Coll, Joseph
    Bullen, Tracey
    Wilson, Judy
    Baylock, Brandi
    Meiser, Bettina
    Price, Melanie
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 116 - 116
  • [37] Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules
    Olsson, H.
    Isfoss, B. L.
    Holmqvist, B.
    Jernstrom, H.
    Alm, P.
    CANCER RESEARCH, 2013, 73
  • [38] Patterns of breast cancer screening among lesbians at increased risk for breast cancer
    Burnett, CB
    Steakley, CS
    Slack, R
    Roth, J
    Lerman, C
    WOMEN & HEALTH, 1999, 29 (04) : 35 - 55
  • [39] Selective screening of breast cancer in women at increased risk: A pilot study.
    Manraj, Shyam Shunker
    Mohith, Anil
    Manraj, Meera
    Kalla, Sumayyah
    Soobrah, Ramawad
    Fauzee, Nilufer Jasmine Selimah
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Molecular Imaging Approaches for Supplemental Screening in Women at Increased Breast Cancer Risk
    Fowler, Amy M.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (05) : 661 - 662